Advertisement

Xofigo® (radium Ra 223 dichloride)

Battle in the Bone

NEW YORK
2018
2018
Entrant Company
Area 23, An FCB Health Network Company
Medium
Print (Pharmaceutical)
Entry Type
Disease Awareness
Thumbnail for Battle in the Bone
View Fullscreen

Items

Credits
Agency NetworkFCB Health Network
Advertiser BrandBayer Pharmaceuticals, Inc./Xofigo® (radium Ra 223 dichloride), Whippany, NJ
Entrant CompanyArea 23, An FCB Health Network Company, New York
Design CompanyLightfarm, Rio de Janeiro
EVP, Managing DirectorTim Hawkey / Area 23, An FCB Health Network Company
SVP, Group Creative DirectorBernardo Romero / Area 23, An FCB Health Network Company
SVP, Creative DirectorJesse Kates / Area 23, An FCB Health Network Company
VP, Associate Creative DirectorDaniel Plansky / Area 23, An FCB Health Network Company
VP, Associate Creative DirectorNathaniel Kuritz / Area 23, An FCB Health Network Company
Group Art SupervisorSandee Shin / Area 23, An FCB Health Network Company
Group Copy SupervisorKatie DeMarco / Area 23, An FCB Health Network Company
Associate Director, Print ProductionFrank Laport / Area 23, An FCB Health Network Company
Senior Production ManagerLaurette Mercer / Area 23, An FCB Health Network Company
SVP, Management DirectorLea Argenti / Area 23, An FCB Health Network Company
Account SupervisorMorgan Carey / Area 23, An FCB Health Network Company
DirectorMilton Menezes / Lightfarm
Creative DirectorRafael Vallaperde / Lightfarm
Production ManagerThadeu Felix / Lightfarm
VP, Account DirectorDespina Mahles

This 2018 Clio Health Silver winning entry titled 'Battle in the Bone' was entered for Xofigo® (radium Ra 223 dichloride) by Area 23, An FCB Health Network Company, New York, part of agency network: FCB Health Network. The piece was submitted to the medium: Print (Pharmaceutical) within the entry type: Disease Awareness. It consists of 1 image.

Advertisement
Advertisement